The largest database of trusted experimental protocols

14 protocols using blasticidine

1

Cell Line Establishment and Genetic Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell lines were grown in Dulbecco's modified Eagle's medium (Lonza, Basel, Switzerland), supplemented with 6% fetal calf serum (Clontech, Mountain View, CA, USA), 50 μg/ml penicillin–streptomycin (Invitrogen, Waltham, MA, USA) and 2 mMl-glutamine (Lonza). Thymidine (2.5 mM) and nocodazole (200 ng/ml) were purchased from Sigma (St Louis, MO, USA). HeLa cells stably expressing H2B-YFP were created using retroviral infection with pBabe-H2B-YFP (kind gift from Dr Susanne Lens, University Medical Center Utrecht, The Netherlands). Cell lines were selected with 5 μg/ml blasticidine (Sigma). U2OS cells stably expressing LAP-Mps1 were infected with retrovirus carrying pBabe-LAP-Mps1 and were selected with 5 μg/ml blasticidine. LAP-Mps1 I531M, I598F, C604Y and S611R were created by site-directed mutagenesis PCR. All cell lines were tested negative for Mycoplasma contamination.
+ Open protocol
+ Expand
2

Generation of Fluorescent Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
VSV-G pseudotyped retroviral particles were produced as described previously49 (link). In short, HEK293T cells were transfected with 10 μg of indicated pRetroX of pLKO vector, combined with 2.5 μg pMD/p and 7.5 μg pMDg plasmids, expressing the gag/pol and envelop proteins, respectively. The supernatant containing retrovirus was harvested at 48–72 h following transfection, was filtered through a 0.45-μM syringe filter and was subsequently used to infect target cells.
Establishment of HeLa cells stably expressing YFP-H2B cells was described previously27 (link). In short, HeLa cells were retrovirally infected with pBabe-H2B-YFP, and selected with blasticidine (5 μgram ml−1, Sigma). To establish KB2P1.21 and KB2P1.21R1 cell lines expressing H2B-EGFP and α-tubulin-mCherry, cells were first transduced with pRetrox-rTTa virus and selected with Geneticin (400 μg ml−1). Subsequently, cells were infected with a pRetrox-Tight-Pur virus harbouring H2B-EGFP–T2A-α-tubulin-mCherry and selected in puromycin (1 μg ml−1). H2B-EGFP and α-tubulin-mCherry expression was induced by incubation with doxycycline (0.5 μg ml−1, Sigma).
+ Open protocol
+ Expand
3

MYCN-Inducible SH-SY5Y Cell Line Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cell culture conditions and cell sources see Duffy et al. [69 (link)]. MYCN overexpression in the SH-SY5Y/6TR(EU)/pTrex-Dest-30/MYCN (SY5Y-MYCN) [69 (link), 70 (link)] line was induced by 1μg/ml Doxycycline (Sigma). SY5Y-MYCN media was supplemented with 7.5μg/ml Blasticidine (Sigma) and 200μg/ml G418 (Sigma). Small molecules used were: CI-1040 (PD184352, Sigma), β-estradiol (Sigma) and Retinoic Acid (RA, Sigma). Stock solutions were dissolved in DMSO, except for β-estradiol for which ethanol was used. Compounds were replenished every 24h for any treatment longer than a 24h duration.
+ Open protocol
+ Expand
4

Lentivirus-Mediated Overexpression and Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirus particles for overexpression and knockdown plasmids were all packaged with pMD2.G, psPAX2 (Addgene). Briefly, 5μg pMD2.G, 5μg psPAX2 and 5μg construct for overexpression or knockdown of specific genes were co-transfected into HEK-293T cells in 100 mm cell culture dish with Effectene Transfection Reagent (301427, Qiagen). The virus particles were harvested at 48 and 72 hours after transfection and concentrated with PEG-it virus precipitation solution (LV810A-1, SBI). For infection, the concentrated virus or the viral supernatant were directly added into cells in the presence of 4ug/ml polybrene (H9268, Sigma-Aldrich) and then spinoculation was conducted at 32°C, 600xg for 60 min. The positive infected cells were selected with 1ug/ml puromycin (P8833, Sigma-Aldrich) or 1mg/ml G418 (10131–027, Thermo Fisher Scientific) or 2.5ug/ml blasticidine (15205, Sigma-Aldrich). After selection, 1ug/ml Doxycycline (D9891, Sigma-Aldrich) was added to induce expression of TRIPZ-shRNAs or Cas9 protein.
+ Open protocol
+ Expand
5

Lentiviral Transduction of NMuMG Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stable populations of NMuMG cells expressing the blasticidine-resistant marker together with TFAP2A-FLAG under a doxycycline-inducible promoter were obtained with the pCLX expression system [26 (link)]. Lentiviral particles were produced in HEK293-LV cells using the helper vectors pMDL, pREV and the envelope-encoding vector pVSV. For infection, viral supernatants were added to target cells in the presence of polybrene (#TR-1003-G, Millipore) (1 μg/ml). Cells were further incubated at 37 °C under 5% CO2 in a tissue culture incubator for 72 h, prior to selection with blasticidine at 10 μg/ml (#15205-25 mg, Sigma-Aldrich).
+ Open protocol
+ Expand
6

Multimodal Senescence Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATM inhibitor KU-55933 (#SML1109), Hoechst 33258 (#14530), E64d (#516485), bafilomycin A1 (#B1793), 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide, MTT (#M2128), blasticidine (#3513-03-9), Fluoromount (#F4680), puromycin (#58-58-2), Quinoline-Val-Asp-Difluorophenoxymethyl Ketone, QVD-OPH (# SML0063) and doxycycline (Dox) (#D9891) were purchased from Sigma-Aldrich. Pepstatin A methyl ester (#516485) and epoxomycin (# 134381-21-8) were obtained from Calbiochem. Tetramethyl rhodamine methyl ester perchlorate dye (#T-668) and carboxyfluorescein succinimidyl ester (CFSE) (#C34554) were purchased from Molecular Probes. LY2603618 (#S2626) was purchased from Selleckchem. 20A was synthesized as previously described (compound #3 in (20 (link))). Sentragor (#AR8850020) for antibody-enhanced detection of senescence cells was provided by Arriani Pharmaceuticals.
+ Open protocol
+ Expand
7

Plasmid Transfection and Cell Selection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following plasmids were employed: E1A12S- and Harvey-Ras- expressing vectors (kindly provided by Dr. G. Piaggio; [49 (link)]), EGFP-expressing vector (pEGFP-c2; Clontech, Mountain View, CA, USA) and pBabepuro (vector expressing the puromycin-resistance marker), GFP-H2B and GFP-H2BS14D (carrying blastictidine-resistance marker; [13 (link)]). Cells were transfected by using Lipofectamine LTX and Plus reagent (Life Technologies) and selected in 2 μg/mL puromycin (Sigma) and/or in 3 μg/mL blasticidine (Sigma).
+ Open protocol
+ Expand
8

Immortalized Endothelial Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human telomerase (hTERT)-immortalized microvascular endothelial cells isolated from human foreskin (TIME cells; ATCC) were grown in ATCC’s vascular cell basal medium supplemented with microvascular endothelial cell growth kit-VEGF and 12.5 μg/ml blasticidine (Sigma-Aldrich) for 48 h at 37°C + 5% CO2 until reaching 80–90% confluence. At confluence, cells were passaged and 5.4 × 104 cells were plated on fibronectin-coated (10 µg/ml; MilliporeSigma), base/acid cleaned, 0.17 mm (#1.5) glass-bottom dishes (14 mm glass diameter; MatTek) for 18 h prior to experiments.
+ Open protocol
+ Expand
9

Neuroblastoma Cell Culture Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cell culture conditions and cell sources see Duffy et al. [1 (link)]. Additionally NBL-S (MYCN single copy, with somewhat elevated MYCN expression [99 (link)]) and BE(2)-C (MYCN-amplified) were used for IC-001 and Wnt Agonist 1 treatment. MYCN overexpression in the SH-SY5Y/6TR(EU)/pTrex-Dest-30/MYCN (SY5Y-MYCN) [1 (link), 67 (link)] line was induced by 1 μg/ml Doxycycline (Sigma-Aldrich). SY5Y-MYCN media was supplemented with 7.5 μg/ml Blasticidine (Sigma- Aldrich) and 200 μg/ml G418 (Sigma-Aldrich). Small molecules used were: 1-azakenpaullone (Azak, Sigma-Aldrich), BIO-acetoxime (BIO, Tocris), Wnt agonist 1 (Merck), ICG-001 (Selleck), iCRT14 (Tocris), and Retinoic Acid (RA, Sigma-Aldrich). Stock solutions were dissolved in DMSO. Compounds were replenished every 24 h for any treatment longer than a 24 h duration.
KCN cells were treated with media containing human recombinant Wnt3a (R&D Systems). The Wnt3a- containing media was replenished 4 times over the course of the 48 h treatment. mβ-catenin/Tcf3 fusion construct (Genbank accession number KM189193) was transfected into the cells using jetPRIME (Polyplus), according to the manufacturer's instructions. Empty or fusion vector was transfected at 100 ng (KCNR) or 200 ng (Kelly) per well of a 96-well plate.
+ Open protocol
+ Expand
10

Sting-/- MEF Reconstitution Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Sting-/- MEFs reconstituted with various Sting rescuing constructs, WT or mutant Sting-GFP was cloned into retroviral MRX-ibsr vector (Saitoh et al., 2009 (link)) (a kind gift from S. Akira) using Eco RI and Not I sites. Retroviruses were packaged in 293T cells and used for infection of Sting-/- MEFs followed by selection with blasticidine (Sigma). For microscopy, Sting-GFP MEFs were grown on cover slides in 12 well plates, and transfected with DNA or infected with bacteria. Cells grown on coverslips were fixed in 4% (wt/vol) paraformaldehyde and were permeabilized and stained by standard protocols. Samples mounted in Vectashield mounting medium containing DAPI (4,6-diamidino-2-phenylindole; Vector Laboratories) were imaged with a Zeiss Imager.M2 fluorescence microscope equipped with AxioVision software. Colocalization quantification by Pearson’s correlation coefficiency was done in SlideBook 5.0 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!